Metformin adherence and the risk of cardiovascular disease: a population-based cohort study
Background: Metformin is a potent antiglycemic agent, but its importance has receded owing to the launch of novel antidiabetic medications. The benefit of metformin includes not only blood sugar control but also anti-inflammation, autophagy activation, and neuroprotection. This study investigated th...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publishing
2023-04-01
|
| Cyfres: | Therapeutic Advances in Chronic Disease |
| Mynediad Ar-lein: | https://doi.org/10.1177/20406223231163115 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|